Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Science 37 Holdings, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Science 37 Reports Second Quarter 2023 Financial Results"
05/15/2023 8-K Quarterly results
Docs: "Science 37 Reports First Quarter 2023 Financial Results"
05/11/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/02/2023 8-K Quarterly results
04/19/2023 8-K Quarterly results
03/13/2023 8-K Other Events  Interactive Data
03/06/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results"
12/30/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
10/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Science 37 appoints Paul von Autenried to its Board of Directors Former Chief Information officer and Executive Committee member for Bristol Myers Squibb brings deep industry and technology expertise to Science 37."
09/30/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/12/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EXECUTIVE EMPLOYMENT AGREEMENT",
"Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer Shipton joins Science 37 to help capitalize on the high demand for decentralized clinical trials and drive further growth into enterprise opportunities."
08/11/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
03/22/2022 8-K Quarterly results
12/20/2021 8-K Quarterly results
11/15/2021 8-K/A Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financi...
Docs: "Warrant Exchange Agreement between LSAQ and the Sponsor",
"Letter Agreements, by and among LSAQ, its officers, its directors and its initial stockholders",
"Science 37 Holders Support Agreement",
"Unaudited pro forma condensed combined financial information of the Company",
"Unaudited condensed consolidated financial statements of the Company as of September 30, 2021 and for the three and nine months ended September 30, 2021 and 2020",
"Management’ s Discussion and Analysis of Financial Condition of the Company as of September 30, 2021 and for the three and nine months ended September 30, 2021 and 2020"
11/15/2021 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Science 37 Reports Quarterly Financial Results for the Period Ended September 30, 2021"
10/13/2021 8-K Quarterly results
10/06/2021 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure
05/07/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Agreement and Plan of Merger, by and among LifeSci Acquisition II Corp., LifeSci Acquisition II Merger Sub, Inc. and Science 37, Inc",
"Sponsor Support Agreement by and among LifeSci Holdings LLC, Science 37, Inc. and LifeSci Acquisition II Corp",
"Form of Subscription Agreement",
"Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future",
"Investor Presentation",
"Script for Investor Call"
12/01/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Balance Sheet"
11/25/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "Underwriting Agreement, by and between the Registrant and LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc",
"Business Combination Marketing Agreement, by and between the Company and LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc",
"Amended and Restated Certificate of Incorporation",
"Private Warrant Agreement",
"Letter Agreements, among the Registrant and the Registrant’ s officers, directors and Initial Stockholders",
"Investment Management Trust Agreement, by and between Continental Stock Transfer & Trust Company and the Registrant",
"Stock Escrow Agreement, among the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders",
"Registration and Stockholder Rights Agreement, by and between the Registrant and Initial Stockholders",
"Subscription Agreement, by and between the Registrant and LifeSci Holdings LLC",
"Administrative Services Agreement, by and between the Registrant and LifeSci Capital LLC"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy